Skip to main content

You are here

We can find a cure

Louise is a leading researcher who is hoping to change the lives of people living with idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD)

Louise Wain a BLF researcher

We breathe over 20,000 breaths a day – usually without even thinking about it. Breathing easily is something that most people take for granted. But as you may know, every breath can be a struggle for some people. This can really impact your life. Not just physically, but emotionally too.

To help people who find it difficult to breathe, like those with COPD and IPF, we must find new treatments and drugs. That’s why I’m researching the DNA of people with and without IPF and COPD.

Research remains at the heart of what we do. But it's underfunded. Will you help fight against lung disease by donating towards research?

Yes I'll donate

I’m wanting to identify if there are differences in DNA which might affect why some people develop IPF or COPD. Or even why some people get more severe symptoms and end up in hospital and why some don’t.

This is really important because it will tell us who is at higher risk of developing COPD or IPF. It will help doctors provide a clearer diagnosis and know what treatment will work best for each patient. 

In the long term, my research will be able to tell doctors and other researchers more about how COPD and IPF progresses. This will help us develop new treatments and drugs for future generations.

It could bring us one step closer to a cure.  

I became a researcher because I am passionate about science and the power my research can have in helping people who live with these conditions.

I’m so grateful to the BLF and their supporters as without their generosity my research just wouldn’t be possible. 

But there aren’t enough of us studying COPD and IPF because there isn’t enough funding.

But there aren’t enough of us studying COPD and IPF because there isn’t enough funding. If more funding was directed towards these conditions, it would also attract more young researchers, whose careers are just starting. In the future, these researchers could make the breakthrough that we’ve been looking for. They could even find a cure for COPD or IPF. But we need your help to do this. You can make a difference.

Help fund vital research like Louise’s so that we can end the suffering caused by lung disease.

Yes I'll donate


Donate towards research now


I have recently been diagnosed with IPF so have been reading up a few details with Dr Googel. For some years I have been interested in the action of glycyrrhizic acid, derived from liquorice, on liver scarring. I believe the commercial product, Phosphogliv is used extensively in Russia to reduce scarring in the liver, often caused by alcohol abuse but also by various other diseases. Do you happen to know if the degradation of the cells in the liver are at all similar to the change in cell structure giving rise to IPF. I doubt if much, if anything is known is known about this, so I propose to try 10mg/day of the acid and see what happens. I have based the dose on a 10:1 safety factor of the lowest "no observable effect" dose of 100 mg/d. If you have any interest in this idea and wish to reply, my email address is
Please call me, I'm treasurer of the Leeds IPF Support Group. We are researching projects to help fund. I'd like to know more. Thanks Tony 07788212737

Add new comment

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
13 June 2018